The disease caused by the virus has been named Coronavirus Disease 2019 (COVID-19). Clinical applications and pharmacological research progress of Lianhua Qingwen capsules/granules. CBP Officers in Chicago Seize 28,800 Prohibited Capsules Objectives: Lianhua Qingwen capsule/granule (LHQW) is an innovative patented traditional Chinese medicine with potential curative effects on respiratory diseases. As explained in the next paragraph, there is currently an outbreak of a respiratory disease named Coronavirus Disease 2019 (COVID-19). The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Advertise With Us, A believer of traditional Chinese medicine, Dr. Cho Chiong Tan clues us in on the medical benefits of this drug and how it can help improve the recovery of COVID patients. The knowledge of the zang- and fu-organs are also consulted in figuring out a detoxification plan for expelling external evil. A Chinese medication, falsely advertising to treat COVID-19, was seized by CBP officers on May 26, 2020. Press the space key then arrow keys to make a selection. [4][7], Lianhua Qingwen should be avoided for patients with G6PD deficiency, since its active ingredient, Lonicera japonica, will lead to hemolysis to such patients. As stated in the research paper published on "Scientific World Journal", Lianhua-Qingwen capsule (LQC) is a commonly used Chinese medical preparation to treat virus and especially played a very important role in the fight against severe acute respiratory syndrome (S-A-R-S) in 2002-2003 in China. It includes forsythia, honeysuckle, ephedra (ma huang), armeniacae, gypsum, isatis, dryopteridis, houttuynia, pogostemon, rheum, rhodiola, Chinese peppermint (bohe), and liquorice. It is your responsibility to ensure that the products you sell are in compliance with the FD&C Act and FDA's implementing regulations. [13], A 2020 "randomized controlled trial" of LHQW involving Zhong was also found in April 2022 to have undisclosed funding from Yiling Pharmaceuticals, forcing an erratum. As the Financial Times report showed, these appeared to be serious conflicts of interest as the investments benefited from the PRC and HK governments' rapid approval and then widespread national & international promotion of Lianhua Qingwen and other suspect treatments for purportedly helping COVID-19 sufferers. COVID-19: TCM Lianhua Qingwen speeds up recovery but no effect in
Jetpack Mifi 8800l Default Admin Password, Has Anyone Not Liked Their House On Hometown, Eternal God Faithful And True Sheet Music, Otto's Gorham Maine Opening Date, Truth Or Dare Mystery Wheel, Articles L